Best Research Foundation Edmonton Near Me

4worldlovers: **We are not able to provide medical advice or offer cancer specialist referrals**


Three of our sisters, Terri, Dianne, and Sue, have put together this poster showing the world-wide distribution of our GCT ‘family’.

4worldlovers: The M.S.I. Foundation is an Alberta-based health research funding organization fostering and supporting research into any aspect of the provision of health and allied services to the people of Alberta, and the promotion of matters of health in the interest of the people of Alberta. It derives its funding from an endowment established in 1970.

Foundations resources will be supporting novice and emerging investigators in the field of health services and population health research according to the following procedures.

4worldlovers: The CANHelp Working Group links University of Alberta researchers with northern community leaders and northern health care providers in a collaborative effort to investigate H. pyloriinfection with the goal of finding solutions to community concerns about health risks from this infection.

Community ProjectsThe CANHelp Working Group began research in Aklavik, Northwest Territories in 2007 because of the high level of concern within the community about health risks from H. pylori infection and support for the research offered by the local health care centre. Since then we have been invited to conduct similar projects in diverse communities throughout the Northwest Territories and Yukon.View Our ProjectsLearn about H. pyloriH. pylori is short for Helicobacter pylori. It is the name of bacteria that infect the stomach. About half of the world population has chronic H. pylori infection, which irritates the stomach lining, causing gastritis. Most people with H. pylori infection don’t feel sick. Some get long-lasting stomach discomfort and a small percent get serious diseases like stomach ulcers, and much more rarely, stomach cancer. Click Here

Exchange knowledge between scientists and concerned community members and health care providers to work together to reduce health risks from this infection

Our research goals, based on the priorities of the participating communities and their health care providers, are to:

Describe the disease burden and risk factors associated with H. pylori infection;

Develop clinical management approaches to reduce health risks from H. pylori infection;

Develop knowledge exchange strategies that help foster a greater understanding of health risks associated with H. pylori infection, as well as solutions and unsolved challenges for reducing these risks.

4worldlovers: TRIO is a unique, full-service clinical research organization (CRO) that leverages the strengths of our worldwide network of Investigators, academic leaders, patient advocates and our clinical research team to accelerate drug development. Working as your partner, we strategically engage to pinpoint the most effective course of action and to optimally conduct cancer clinical trials.

Oncology is not just another indication in our portfolio. It’s the only one, and it’s our specialty. We understand the therapeutic area, the challenges and the complexities associated with expediting cancer clinical trials. That’s why TRIO Operations is supported by a team of global Key Opinion Leaders who provide input on trial design and execution, promote our trials to accelerate enrollment and critically analyze results.

All of our phase III trials have completed enrollment on time, if not earlier! Four of the registration trials we’ve conducted have led to approval, changing the lives of countless cancer patients worldwide. We have also developed our expertise in early phase trials, including First-In Human (FIH) studies. This has propelled us to become protagonists across the full drug development pathway.

We have world-class leadership and operation teams whose main goal is to optimize trial start-up and execution—all while maintaining high-quality and effective collaboration with our Sponsors and Investigators. Over the decades, we’ve built a reputation for long-term partnerships with our customers that are based on success and trust.

We’re proud of having built a Top Tier Network of over 500 highly experienced, sought-after investigational sites, spanning more than 20 countries and four continents. Our network has been paramount to our successes.

TRIO conducts cancer clinical trials internationally, over four continents. We keep our structure lean with three operational hubs and staff presence in over 20 countries.

A unique CRO, TRIO gives team members the opportunity to grow their careers in a flexible, supportive environment where work/life balance is woven into the fabric of everything we do. Driven by science and fueled by our values, our team enjoys rewarding work that brings real changes to the lives of cancer patients and propels advancements in cancer clinical trials around the world. Looking to develop your skills and make a difference? Look no further!

NATALEE (TRIO033) Phase III trial demonstrates ribociclib significantly reduces the risk of recurrence for patients with early breast cancer, at interim analysis

Translational Research In Oncology (TRIO) today announced positive topline results from NATALEE (TRIO033), a Novartis sponsored Phase III trial of ribociclib plus endocrine therapy (ET)…

TRIO is proud to be on the 2023 list of Canada’s Top Small and Medium Employers for the 3rd year in a row

For a third year in a row! We are very proud to be on a list with a great group of employers. Our people are…

TRIO ranks 4th among Uruguay’s best workplaces in 2023 as chosen by Great Place to Work

After obtaining the Great Place to Work certification in 2022, we are happy to announce that TRIO Uruguay has been ranked fourth among Uruguay’s best…

At TRIO, we work as your partner to deliver quality oncology trials internationally, accelerate your drug development and improve the lives of patients with cancer. Learn how TRIO can support your oncology clinical study.